<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04352426</url>
  </required_header>
  <id_info>
    <org_study_id>busra.alkan</org_study_id>
    <nct_id>NCT04352426</nct_id>
  </id_info>
  <brief_title>Symptom-limited Stair Climbing Test in Heart Failure</brief_title>
  <official_title>Effectiveness of Symptom-limited Stair-climbing Test in the Determination of the Exercise Capacity of Patients With Chronic Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KTO Karatay University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>KTO Karatay University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aims: To assess the efficacy of symptom-limited stair-climbing test (SLSCT), in determining
      the exercise capacities of patients with chronic heart failure (CHF) in comparison with
      cardiopulmonary exercise test (CPET) and 6-minute walk test(6MWT) and to interpret the
      results according to the clinical status of the patients.

      Methods: Thirty-one patients, aged 50-75 years, with stage II-III CHF according to the New
      York Heart Association Classification and left ventricular ejection fraction (LVEF) of ≤45%
      were included. The demographic and clinical characteristics of the patients were recorded.
      Exercise capacity was assessed by SLSCT, 6MWT, and CPET. The duration of patients'
      performance in the test, reasons for ending the test and predicted maximal oxygen consumption
      (VO2max) were recorded. Heart rate (HR), blood pressure (BP), dyspnoea severity [Modified
      Borg Scale (MBS)] and peripheral oxygen saturation were recorded. Pulmonary functions were
      assessed by spirometry.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 13, 2017</start_date>
  <completion_date type="Actual">November 12, 2017</completion_date>
  <primary_completion_date type="Actual">November 10, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Symptom-Limited Stair-Climbing Test(SLSCT)</measure>
    <time_frame>baseline</time_frame>
    <description>predicted VO2 max (ml/kg/min)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Six-Minute Walk Test(6MWT)</measure>
    <time_frame>baseline</time_frame>
    <description>predicted VO2 max (ml/kg/min)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiopulmonary Exercise Test(CPET)</measure>
    <time_frame>baseline</time_frame>
    <description>predicted VO2 max (ml/kg/min)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>immediately after the procedure</time_frame>
    <description>Heart Rate beats/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left Ventricular Ejection Fraction</measure>
    <time_frame>baseline</time_frame>
    <description>Ecocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>immediately after the procedure</time_frame>
    <description>Systolic and diastolic blood pressure (mmHg)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>FVC l/sec</measure>
    <time_frame>baseline</time_frame>
    <description>Forced Vital Capacity l/sec</description>
  </other_outcome>
  <other_outcome>
    <measure>FEF 25-75 l/sec</measure>
    <time_frame>baseline</time_frame>
    <description>Forced Expiratory Flow 25-75 l/sec</description>
  </other_outcome>
  <other_outcome>
    <measure>PEF l/sec</measure>
    <time_frame>baseline</time_frame>
    <description>Peak Expiratory Flow l/sec</description>
  </other_outcome>
  <other_outcome>
    <measure>FEV1 %</measure>
    <time_frame>baseline</time_frame>
    <description>Forced Expiratory Volume in One Second %</description>
  </other_outcome>
  <other_outcome>
    <measure>FVC %</measure>
    <time_frame>baseline</time_frame>
    <description>Forced Vital Capacity %</description>
  </other_outcome>
  <other_outcome>
    <measure>FEF 25-75 %</measure>
    <time_frame>baseline</time_frame>
    <description>Forced Expiratory Flow %</description>
  </other_outcome>
  <other_outcome>
    <measure>PEF %</measure>
    <time_frame>baseline</time_frame>
    <description>Peak Expiratory Flow %</description>
  </other_outcome>
  <other_outcome>
    <measure>FEV1 l/sec</measure>
    <time_frame>bseline</time_frame>
    <description>Forced Vital Capacity l/sec</description>
  </other_outcome>
  <other_outcome>
    <measure>FEV1/FVC</measure>
    <time_frame>bseline</time_frame>
    <description>FEV1/FVC %</description>
  </other_outcome>
  <enrollment type="Actual">31</enrollment>
  <condition>Chronic Heart Failure</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise Test</intervention_name>
    <description>Tests were conducted to evaluate exercise capacity.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Thirty-one patients age 65.52±7.57 years with stage II-III according to the NYHA
        classification, diagnosed with CHF, with a LVEF of 45% or less admitted to study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  50-75 years of age

          -  NYHA stage II-III

          -  LVEF of 45% or less

          -  Independently walking and climbing stairs

          -  Volunteer to participate in research

        Exclusion Criteria:

          -  Any acute or chronic condition that would limit exercise capacity other than CHF

          -  Insufficient mental status to perform tests and surveys

          -  Orthopaedic problem limiting exercise test in lower extremity

          -  Severe obesity or there is a secondary cause for obesity

          -  Uncontrolled cardiac arrhythmia

          -  Unstable angina
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 6, 2020</study_first_submitted>
  <study_first_submitted_qc>April 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2020</study_first_posted>
  <last_update_submitted>April 15, 2020</last_update_submitted>
  <last_update_submitted_qc>April 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic heart failure</keyword>
  <keyword>exercise capacity</keyword>
  <keyword>symptom-limited stair-climbing test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

